References
- Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Prim. 2017;3:1–19.
- Logroscino G, Traynor BJ, Hardiman O, Chió A, Mitchell D, Swingler RJ, EURALS, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
- Marin B, Boumé diene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in world wide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
- Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
- Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Eurals Consortium, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
- Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci. 2001;191:3–9.
- Hobson EV, McDermott CJ. Supportive and symptomatic management of amyotrophic lateral sclerosis. Nat Rev Neurol. 2016;12:526–38. Available at: http://dx.doi.org/10.1038/nrneurol.2016.111
- Mistry KK, Simpson J. Exploring the transitional process from receiving a diagnosis to living with motor neurone disease. Psychol Heal. 2013;28:37–41. Available at: http://eprints.lancs.ac.uk/61884/
- Oliver D, Borasio GD, Walsh D. Palliative care in amyotrophic lateral sclerosis: from diagnosis to bereavement. Oxford: Oxford University Press; 2011:1–364 p.
- Zarotti N, Coates E, McGeachan A, Williams I, Beever D, Hackney G, HighCALS Study Group, et al. Health care professionals' views on psychological factors affecting nutritional behaviour in people with motor neuron disease: a thematic analysis. Br J Health Psychol. 2019;24:953–69. Available at: https://search.ebscohost.com/login.aspx?direct=true&db=psyh&AN=2019-51081-001&authtype=sso&custid=s8993828&site=ehost-live
- Maes S, Leventhal H, de Ridder D. Coping with chronic diseases. In: Zeidner M, Endler NS, eds. Handbook of coping: theory, research, applications. Oxford, England: John Wiley & Sons; 1996:221–51. Available at: http://psycnet.apa.org/record/1996-97004-011
- Stanton AL, Revenson TA. Adjustment to chronic disease: progress and promise in research. In: Howard S. Friedman (ed.) The Oxford handbook of health psychology. New York: Oxford University Press; 2012: 241–68. Available at: http://oxfordhandbooks.com/view/10.1093/oxfordhb/9780195342819.001.0001/oxfordhb-9780195342819-e-011
- Hogg KE, Goldstein LH, Leigh PN. The psychological impact of motor neurone disease. Psychol Med. 1994;24:625–32.
- Lee JN, Rigby SA, Burchardt F, Thornton EW, Dougan C, Young CA. Quality of life issues in motor neurone disease: the development and validation of a coping strategies questionnaire, the MND Coping Scale. J Neurol Sci. 2001;191:79–85.
- Goldstein LH, Atkins L, Landau S, Brown RG, Leigh PN. Longitudinal predictors of psychological distress and self-esteem in people with ALS. Neurology. 2006;67:1652–8.
- Hillemacher T, Grässel E, Tigges S, Bleich S, Neundörfer B, Kornhuber J, et al. Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:245–9.
- Walshe M, Peach RK, Miller N. Dysarthria impact profile: development of a scale to measure psychosocial effects. Int J Lang Commun Disord. 2009;44:693–715.
- Hecht M, Hillemacher T, Gräsel E, Tigges S, Winterholler M, Heuss D, et al. Subjective experience and coping in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3:225–32.
- Walshe M, Miller N. Living with acquired dysarthria: the speaker’s perspective. Disabil Rehabil. 2011;33:195–203. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20735274
- Dickson S, Barbour RS, Brady M, Clark AM, Paton G. Patients' experiences of disruptions associated with post-stroke dysarthria. Int J Lang Commun Disord. 2008;43:135–53.
- Borasio GD, Miller RG. Clinical characteristics and management of ALS. Semin Neurol. 2001;21:155–66. Available at: http://www.thieme-connect.de/DOI/DOI?10.1055/s-2001-15268
- Muscaritoli M, Kushta I, Molfino A, Inghilleri M, Sabatelli M, Rossi Fanelli F. Nutritional and metabolic support in patients with amyotrophic lateral sclerosis. Nutrition. 2012;28:959–66.
- Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001;248:612–6.
- Greenwood DI. Nutrition management of amyotrophic lateral sclerosis. Nutr Clin Pract. 2013;28:392–9.
- Johnson J, Leigh PN, Shaw CE, Ellis C, Burman R, Al-Chalabi A. Eating-derived pleasure in amyotrophic lateral sclerosis as a predictor of non-oral feeding. Amyotroph Lateral Scler. 2012;13:555–9.
- Stavroulakis T, Baird WO, Baxter SK, Walsh T, Shaw PJ, McDermott CJ. Factors influencing decision-making in relation to timing of gastrostomy insertion in patients with motor neurone disease. BMJ Support Palliat Care. 2014;4:57–63.
- Stavroulakis T, Baird WO, Baxter SK, Walsh T, Shaw PJ, McDermott CJ. The impact of gastrostomy in motor neurone disease: challenges and benefits from a patient and carer perspective. BMJ Support Palliat Care. 2016;6:52–9.
- King SJ, Duke MM, O'Connor BA. Living with amyotrophic lateral sclerosis/motor neurone disease (ALS/MND): decision-making about “ongoing change and adaptation”. J Clin Nurs. 2009;18:745–54.
- Oliver DJ, Turner MR. Some difficult decisions in ALS/MND. Amyotroph Lateral Scler. 2010;11:339–43.
- Foley G, Timonen V, Hardiman O. Understanding psycho-social processes underpinning engagement with services in motor neurone disease: a qualitative study. Palliat Med. 2014;28:318–25.
- Abrahams S. ALS, cognition and the clinic. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:3–5.
- Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): a cognitive tool for motor disorders. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:172–9.
- Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
- Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586–90. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8351013
- Genet JJ, Siemer M. Flexible control in processing affective and non-affective material predicts individual differences in trait resilience. Cogn Emot. 2011;25:380–8.
- Pagnini F, Simmons Z, Corbo M, Molinari E. Amyotrophic lateral sclerosis: time for research on psychological intervention? Amyotroph Lateral Scler. 2012;13:416–7.
- Weeks KR, Gould RL, Mcdermott C, Lynch J, Goldstein LH, Graham CD, et al. Needs and preferences for psychological interventions of people with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:521–31. Available at:
- Gould RL, Coulson MC, Brown RG, Goldstein LH, Al-Chalabi A, Howard RJ. Psychotherapy and pharmacotherapy interventions to reduce distress or improve well-being in people with amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:293–302. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26174444
- NICE. Motor Neurone Disease: Assessment and Management [Internet]. 2016. Available at: https://www.nice.org.uk/guidance/ng42/evidence/full-guideline-pdf-2361774637%0Ahttp://www.ncbi.nlm.nih.gov/pubmed/26962594
- Clare L, Teale JC, Toms G, Kudlicka A, Evans I, Abrahams S, et al. Cognitive rehabilitation, self-management, psychotherapeutic and caregiver support interventions in progressive neurodegenerative conditions: a scoping review. NeuroRehabilitation. 2018;43:443–71. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30412509
- Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13:141–6.
- Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32. Available at: http://www.scopus.com/inward/record.url?eid=2-s2.0-14644388070&partnerID=tZOtx3y1
- Mays N, Roberts E, Popay J. Synthesising research evidence. In: Fulop N, Allen P, Clarke A, Black N, eds. Studying the organisation and delivery of health services: research methods. London: Routledge; 2001:188–219.
- Pham MT, Rajić A, Greig JD, Sargeant JM, Papadopoulos A, Mcewen SA. A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Res Synth Methods. 2014;5:371–85.
- Averill AJ, Kasarskis EJ, Segerstrom SC. Expressive disclosure to improve well-being in patients with amyotrophic lateral sclerosis: a randomised, controlled trial. Psychol Health. 2013;28:701–13.
- Pagnini F, Marconi A, Tagliaferri A, Manzoni GM, Gatto R, Fabiani V, et al. Meditation training for people with amyotrophic lateral sclerosis: a randomized clinical trial. Eur J Neurol. Neurol. 2017;24:578–86. Available at: https://www.ncbi.nlm.nih.gov/pubmed/28229508
- Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. New York, NY: Delta; 1990.
- Marconi A, Gragnano G, Lunetta C, Gatto R, Fabiani V, Tagliaferri A, et al. The experience of meditation for people with amyotrophic lateral sclerosis and their caregivers – a qualitative analysis. Psychol Health Med. 2016;21:762–8. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26584831
- Van Groenestijn AC, Schröder CD, Visser-Meily JMA, Reenen EV, Veldink JH, Van Den Berg LH. Cognitive behavioural therapy and quality of life in psychologically distressed patients with amyotrophic lateral sclerosis and their caregivers: results of a prematurely stopped randomized controlled trial. Amyotroph Lateral Scler Front Degener. 2015;16:309–15. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26087303
- Díaz JL, Sancho J, Barreto P, Bañuls P, Renovell M, Servera E. Effect of a short-term psychological intervention on the anxiety and depression of amyotrophic lateral sclerosis patients. J Health Psychol. 2016;21:1426–35. Available at: https://www.ncbi.nlm.nih.gov/pubmed/25370571
- Palmieri A, Kleinbub JR, Calvo V, Soraru G, Grasso I, Messina I, et al. Efficacy of hypnosis-based treatment in amyotrophic lateral sclerosis: a pilot study. Front Psychol. 2012;3:465. Available at: https://www.ncbi.nlm.nih.gov/pubmed/23162510
- Kleinbub JR, Palmieri A, Broggio A, Pagnini F, Benelli E, Sambin M, et al. Hypnosis-based psychodynamic treatment in ALS: a longitudinal study on patients and their caregivers. Front Psychol. 2015;6:822. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26136710
- Aoun SM, Chochinov HM, Kristjanson LJ. Dignity therapy for people with motor neuron disease and their family caregivers: a feasibility study. J Palliat Med. 2015;18:31–7. Available at: https://www.ncbi.nlm.nih.gov/pubmed/25314244
- Bentley B, O'Connor M, Kane R, Breen LJ. Feasibility, acceptability, and potential effectiveness of dignity therapy for people with motor neurone disease. PLoS One. 2014;9:e96888. Available at: https://www.ncbi.nlm.nih.gov/pubmed/24816742
- Garcia Perez AI, Dapueto JJ. Case report of a computer-assisted psychotherapy of a patient with ALS. Int J Psychiatry Med. 2014;48:229–33. Available at: https://www.ncbi.nlm.nih.gov/pubmed/25492716
- Kurt A, Nijboer F, Matuz T, Kübler A. Depression and anxiety in individuals with amyotrophic lateral sclerosis. CNS Drugs. 2007;21:279–91. Available at: https://vpn.nacs.uci.edu/+CSCO+0h756767633A2F2F797661782E66636576617472652E70627A++/article/10.2165/00023210-200721040-00003/fulltext.html
- Goldstein LH, Leigh PN. Motor neurone disease: a review of its emotional and cognitive consequences for patients and its impact on carers. Br J Health Psychol. 1999;4:193–208.
- Zimmerman EK, Eslinger PJ, Simmons Z, Barrett AM. Emotional perception deficits in amyotrophic lateral sclerosis. Cogn Behav Neurol. 2007;20:79–82.
- Bungener C, Unglik J, Lacomblez L. Emotional regulation in amyotrophic lateral sclerosis. Int J Neurorehabilitation 2017;04:4–5.
- Savage SA, Lillo P, Kumfor F, Kiernan MC, Piguet O, Hodges JR. Emotion processing deficits distinguish pure amyotrophic lateral sclerosis from frontotemporal dementia. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:39–46.
- Aho-Özhan HEA, Keller J, Heimrath J, Uttner I, Kassubek J, Birbaumer N, et al. Perception of emotional facial expressions in amyotrophic lateral sclerosis (ALS) at behavioural and brain metabolic level. PLoS One. 2016;11:e0164655.
- Abdulla S, Vielhaber S, Kollewe K, Machts J, Heinze H-J, Dengler R, et al. The impact of physical impairment on emotional well-being in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:392–7.
- Simmons Z, Bremer BA, Robbins RA, Walsh SM, Fischer S. Quality of life in ALS depends on factors other than strength and physical function. Neurology. 2000;55:388–92. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10932273
- Sandstedt P, Johansson S, Ytterberg C, Ingre C, Holmqvist LW, Kierkegaard M. Predictors of health-related quality of life in people with amyotrophic lateral sclerosis. J Neurol Sci. 2016;370:269–73. Available at: http://dx.doi.org/10.1016/j.jns.2016.09.034
- Chiò A, Gauthier A, Montuschi A, Calvo A, Di Vito N, Ghiglione P, et al. A cross sectional study on determinants of qualify of life in ALS. J Neurol Neurosurg Psychiatry 2004;75:1597–601.
- van Groenestijn AC, Kruitwagen-van Reenen ET, Visser-Meily JMA, van den Berg LH, Schröder CD. Associations between psychological factors and health-related quality of life and global quality of life in patients with ALS: a systematic review. Health Qual Life Outcomes. 2016;14:1–20. Available at: http://dx.doi.org/10.1186/s12955-016-0507-6
- Serfaty M, Armstrong M, Vickerstaff V, Davis S, Gola A, McNamee P, et al. Acceptance and commitment therapy for adults with advanced cancer (CanACT): a feasibility randomised controlled trial. Psychooncology. 2019;28:488–96.
- Davis EL, Deane FP, Lyons GCB, Barclay GD, Bourne J, Connolly V. Feasibility randomised controlled trial of a self-help acceptance and commitment therapy intervention for grief and psychological distress in carers of palliative care patients. J Health Psychol. 2020;25:322–39.
- Bennett-Levy J, Richards D, Farrand P, Christensen H, Griffiths K, Kavanagh K, et al. editors. Oxford guide to low intensity CBT interventions. New York: Oxford University Press; 2010.
- NICE. Depression in adults with a chronic physical health problem: recognition and management (CG91). 2009.
- Ferentinos P, Paparrigopoulos T, Rentzos M, Zouvelou V, Alexakis T, Evdokimidis I. Prevalence of major depression in ALS: comparison of a semi-structured interview and four self-report measures. Amyotroph Lateral Scler. 2011;12:297–302.
- Ovaska-Stafford N, Maltby J, Dale M. Literature review: psychological resilience factors in people with neurodegenerative diseases. Arch Clin Neuropsychol. 2019;0:1–24.
- Loane SS, D'Alessandro S. Communication that changes lives: social support within an online health community for ALS. Commun Q. 2013;61:236–51. Available at: internal-pdf://125.114.154.145/Communication That Changes Lives.pdf%5Cnhttp://ezproxy.library.yorku.ca/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=cms&AN=86994681&site=ehost-live
- Matuz T, Birbaumer N, Hautzinger M, Kübler A. Psychosocial adjustment to ALS: a longitudinal study. Front Psychol. 2015;6:1–12.
- Essat M, Archer R, Williams I, Zarotti N, Coates E, Clowes M. Interventions to promote oral nutritional behaviours in people living with neurodegenerative disorders of the motor system: a systematic review. Clin Nutr. 2019. Available at: https://www.sciencedirect.com/science/article/abs/pii/S0261561419331425?fbclid=IwAR1By2xNXRRfQfukuVyCUwHRcK3BylWntMHktIANacNySYQ-mdzNq2YGIkI#
- Goodrich E, Wahbeh H, Mooney A, Miller M, Oken BS. Teaching mindfulness meditation to adults with severe speech and physical impairments: an exploratory study. Neuropsychol Rehabil. 2015;25:708–32. Available at: https://www.ncbi.nlm.nih.gov/pubmed/25338503
- Pagnini F, Di Credico C, Gatto R, Fabiani V, Rossi G, Lunetta C, et al. Meditation training for people with amyotrophic lateral sclerosis and their caregivers. J Altern Complement Med. 2014;20:272–5. Available at: https://www.ncbi.nlm.nih.gov/pubmed/24328393
- Rabbitte M, Bates U, Keane M. Psychological and psychotherapeutic approaches for people with motor neuron disease: a qualitative study. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:303–8. Available at: https://www.ncbi.nlm.nih.gov/pubmed/25734219
- van Groenestijn AC, van de Port IG, Schroder CD, Post MW, Grupstra HF, Kruitwagen ET, et al. Effects of aerobic exercise therapy and cognitive behavioural therapy on functioning and quality of life in amyotrophic lateral sclerosis: protocol of the FACTS-2-ALS trial. BMC Neurol. 2011;11:70. Available at: http://www.biomedcentral.com/1471-2377/11/70